摘要
文中通过对近年来国内化学药品研发申报的现状进行分析,结果显示我国目前是以仿制药申报为主,并逐步转向仿创结合的模式。结合在创新药研发中制药企业存在的不足,文中提出将建立创新药整体研发思路、构建适应创新研发学科需要的团队以及提高沟通交流能力作为提高我国创新药研发的关键要素。
Through analysis in chemical drug submission in recent years,the current situation is confirmed.The results show that primary submissions are generic drugs,and the submission involving investigational new drug （IND） is increasing.Based on the shortcoming in IND research and development of Chinese industries,some key factors need to improve,including establishing the systematical research and development strategy,organizing the whole team,improving the communication,and so on.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2010年第7期558-560,共3页
Chinese Journal of New Drugs
关键词
创新药
申报
关键要素
研发
investigational new drug
submission
key factor
research and development
